Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: AIM ImmunoTech Inc., 3 years.
AIM ImmunoTech Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AIM ImmunoTech Inc. December 17, 202449.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 31, 2024 | AIM ImmunoTech Inc. | Grant or award | +8,768 | $0.20 | $1,754 |
| Dec 13, 2024 | AIM ImmunoTech Inc. | Grant or award | +24,452 | $0.21 | $5,135 |
| Dec 2, 2024 | AIM ImmunoTech Inc. | Open-market purchase | +1 | $0.21 | $0 |
| Dec 2, 2024 | AIM ImmunoTech Inc. | Grant or award | +22,645 | $0.23 | $5,208 |
| Dec 2, 2024 | AIM ImmunoTech Inc. | Open-market purchase | +11,111 | $0.21 | $2,333 |
| Nov 20, 2024 | AIM ImmunoTech Inc. | Open-market purchase | +81,953 | $0.19 | $15,571 |
| Mar 15, 2024 | AIM ImmunoTech Inc. | Open-market purchase | +90,910 | $0.33 | $30,000 |
| Mar 10, 2023 | AIM ImmunoTech Inc. | Other | −68,208 | $1.23 | $83,896 |
| Jan 3, 2023 | AIM ImmunoTech Inc. | Open-market purchase | +80,646 | $0.31 | $25,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.